Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3406]
News [7759]
Articles [63]
Editorials [9]
Conferences [207]
elearning [49]
MET inhibitors for non-small cell lung cancer
Prof Georgio Scagliotti – University of Torino, Italy
MET inhibitors for non-small cell lung cancer ( Prof Georgio Scagliotti – University of Torino, Italy )
9 Oct 2012
Multidisciplinary benefits to radiotherapy
Prof Vincenzo Valentini – President of ESTRO
Multidisciplinary benefits to radiotherapy ( Prof Vincenzo Valentini – President of ESTRO )
9 Oct 2012
Putting the theory of personalised medicine into practice
Prof Fabrice Andre, Dr Ramesh Ramanathan, Prof Peter Harper and Prof Robert...
Putting the theory of personalised medicine into practice ( Prof Fabrice Andre, Dr Ramesh Ramanathan, Prof Peter Harper and Prof Robert Leonard )
8 Oct 2012
Treatment of ALK+ lung cancer with crizotinib, Profile 1007
Dr Alice Shaw – Massachusetts General Hospital, Boston, USA
Treatment of ALK+ lung cancer with crizotinib, Profile 1007 ( Dr Alice Shaw – Massachusetts General Hospital, Boston, USA )
8 Oct 2012
Phase III MISSION trial: Sorafenib does not extend overall survival as third or...
Dr Tony Mok – The Chinese University of Hong Kong
Phase III MISSION trial: Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer ( Dr Tony Mok – The Chinese University of Hong Kong )
8 Oct 2012
Trametinib and dabrafenib combination therapy against metastatic melanoma
Dr Georgina Long – Westmead Hospital, The University of Sydney, Australia
Trametinib and dabrafenib combination therapy against metastatic melanoma ( Dr Georgina Long – Westmead Hospital, The University of Sydney, Australia )
8 Oct 2012
Personalised cancer medicine and research: Today’s best practice
Prof José Baselga - Massachusetts General Hospital, Boston, USA
Personalised cancer medicine and research: Today’s best practice ( Prof José Baselga - Massachusetts General Hospital, Boston, USA )
5 Oct 2012
Putting drugs to work against brain metastases in HER2 positive breast cancer:...
Dr Thomas Bachelot – Centre Leon Berard, Lyon
Putting drugs to work against brain metastases in HER2 positive breast cancer: LANDSCAPE study ( Dr Thomas Bachelot – Centre Leon Berard, Lyon )
4 Oct 2012
Phase I study examining PI 3 kinase inhibitor for various tumours
Dr Pamela Munster – University of California, San Francisco, USA
Phase I study examining PI 3 kinase inhibitor for various tumours ( Dr Pamela Munster – University of California, San Francisco, USA )
4 Oct 2012
Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK...
Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA
Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )
30 Sep 2012
A proof-of-concept study of ODM-201 in patients with progressive castration...
Dr Christophe Massard - Institute Gustave Roussy, Paris, France
A proof-of-concept study of ODM-201 in patients with progressive castration-resistant prostate cancer ( Dr Christophe Massard - Institute Gustave Roussy, Paris, France )
30 Sep 2012
Too few women being offered breast-conserving treatment?
Dr Carmen Criscitiello - European Institute of Oncology in Milan, Italy
Too few women being offered breast-conserving treatment? ( Dr Carmen Criscitiello - European Institute of Oncology in Milan, Italy )
30 Sep 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation